ERIC DOBMEIER Insider Trading $ADRO CHINOOK THERAPEUTICS, INC.
Get free email notifications about insider trading for ERIC DOBMEIER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ERIC DOBMEIER. ERIC DOBMEIER is Chief Business Officer in SEATTLE GENETICS INC /WA ($SGEN) and Chief Operating Officer in SEATTLE GENETICS INC /WA ($SGEN) and Sr. VP, Corporate Development in SEATTLE GENETICS INC /WA ($SGEN) and V. P., Corporate Affairs in SEATTLE GENETICS INC /WA ($SGEN) and Vice President, in SEATTLE GENETICS INC /WA ($SGEN) and Director in STEMLINE THERAPEUTICS INC ($STML) and President, CEO in ADURO BIOTECH, INC. ($ADRO) and Director in Adaptive Biotechnologies Corp ($ADPT) and Director in Versartis, Inc. ($VSAR) and Director in Atara Biotherapeutics, Inc. ($ATRA).
ERIC DOBMEIER in CHINOOK THERAPEUTICS, INC.
Trading Symbol: ADROIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ERIC DOBMEIER: President, CEO
Holdings: 97,837 shares
Current Value: $1,095,774
Latest Transaction: Jun 15 2021
$ADRO Market Capitalization: $745.72M
$ADRO Previous Close: $11.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ERIC DOBMEIER in CHINOOK THERAPEUTICS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADPT, ARAV, ATRA, ADRO, SGEN, STML
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2021 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Option Exercise | M | 0.35 | 20,000 | 7,000 | 423,358 | |
Jun 15 2021 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | M | 0.35 | 20,000 | 7,000 | 97,837 | 77.8 K to 97.8 K (+25.69 %) |
Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 0.00 | 60,743 | 0 | 60,743 | |
Feb 12 2021 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 15.14 | 178,600 | 2,704,004 | 178,600 | |
Dec 22 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Option Exercise | M | 0.35 | 20,000 | 7,000 | 443,358 | |
Dec 22 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | M | 0.35 | 20,000 | 7,000 | 76,837 | 56.8 K to 76.8 K (+35.19 %) |
Dec 10 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | P | 13.08 | 2,000 | 26,150 | 56,837 | 54.8 K to 56.8 K (+3.65 %) |
Dec 10 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | P | 13.24 | 2,000 | 26,483 | 54,837 | 52.8 K to 54.8 K (+3.79 %) |
Nov 23 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | P | 13.67 | 929 | 12,699 | 52,837 | 51.9 K to 52.8 K (+1.79 %) |
Nov 23 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | P | 13.69 | 571 | 7,817 | 51,908 | 51.3 K to 51.9 K (+1.11 %) |
Nov 23 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | P | 13.50 | 500 | 6,750 | 51,337 | 50.8 K to 51.3 K (+0.98 %) |
Nov 13 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | P | 13.75 | 2,500 | 34,375 | 50,837 | 48.3 K to 50.8 K (+5.17 %) |
Nov 13 2020 | ADRO | CHINOOK THERAPEUTI ... | DOBMEIER ERIC | President, CEO | Buy | P | 13.86 | 2,000 | 27,720 | 48,337 | 46.3 K to 48.3 K (+4.32 %) |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 0.00 | 92,389 | 0 | 92,389 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 0.00 | 92,389 | 0 | 92,389 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 14.77 | 271,647 | 4,012,226 | 271,647 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 14.77 | 271,647 | 4,012,226 | 271,647 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 0.42 | 423,555 | 177,893 | 423,555 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 0.42 | 423,555 | 177,893 | 423,555 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 0.35 | 463,358 | 162,175 | 463,358 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Option Exercise | A | 0.35 | 463,358 | 162,175 | 463,358 | |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Grant | A | 0.00 | 46,337 | 0 | 46,337 | 0 to 46.3 K |
Oct 07 2020 | ADRO | ADURO BIOTECH, INC ... | DOBMEIER ERIC | President, CEO | Grant | A | 0.00 | 46,337 | 0 | 46,337 | 0 to 46.3 K |
Page: 1